Publication Cover
Human Fertility
an international, multidisciplinary journal dedicated to furthering research and promoting good practice
Volume 17, 2014 - Issue 2
585
Views
10
CrossRef citations to date
0
Altmetric
Newspaper articles and ART

What's the message? A content analysis of newspaper articles about assisted reproductive technology from 2005 to 2011

, , , , &
Pages 124-132 | Received 30 Aug 2013, Accepted 04 Nov 2013, Published online: 26 Mar 2014
 

Abstract

Infertility and its treatment is the subject of considerable media coverage. In order to evaluate the representation of assisted reproductive technology (ART) in the popular media, we conducted a content analysis of North American newspaper articles. We also explored whether different themes emerged in relation to the implementation of public funding for ART in Quebec, Canada. Print and online newspaper articles from 2005 to 2011 were retrieved using the terms “in-vitro fertilization”, “infertility treatment”, “assisted reproductive technology”, and “IVF treatment”. Totally, 719 newspaper articles met inclusion criteria and were coded according to predetermined categories. Risks (63%) and ethical issues (61%) related to ART were most commonly featured. Quebec-based articles were mostly concerned with the politics and financial issues governing ART, and were less likely to report the risks and emotional impact of ART than other North American press. Newspapers tended to emphasize extreme scenarios as well as controversial cases that may not represent the everyday realities of ART. Changes in public policy may also engender shifts in the tone and content of media reports. It is important to establish resources that can inform the public as well as prospective infertility patients about their condition and potential treatment options.

Acknowledgments

The authors would like to thank Ninat Friedland, Marie-Eve Boucher, Evan Newton and Marie-Eve Carrier for their assistance in coding the articles.

Declaration of interest: The authors report no declarations of interest. The authors alone are responsible for the content and writing of the paper.Togas Tulandi is an advisor for Watson Pharma.This research was supported by grant number: PAH 103596 from the Canadian Institutes of Health Research (CIHR).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.